...
首页> 外文期刊>Pain Physician >Effect of a Fixed-Dose Opioid Agonist/Antagonist on Constipation in Patients on Long-term Opioids for Non-Malignant Pain Unable to Tolerate Laxatives
【24h】

Effect of a Fixed-Dose Opioid Agonist/Antagonist on Constipation in Patients on Long-term Opioids for Non-Malignant Pain Unable to Tolerate Laxatives

机译:固定剂量阿片类激动剂/拮抗剂对患者便秘的长期阿片类药物的耐受性,不能耐受泻药的非恶性疼痛。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Chronic pain affects a large number of patients throughout the world and impacts greatly on their quality of life, including the ability of a patient to sleep, go to work, and socialize. Guidance on the use of opioids in chronic pain patients is available from the British Pain Society; however, patients receiving opioid treatment for their pain often suffer from symptoms associated with opioid-induced bowel dysfunction (OIBD), including constipation. The usual treatment of constipation in these patients is laxatives; however, one study has shown that 54% of patients do not receive the desired results from this approach. Oxycodonealoxone tablets have been shown to provide analgesia to chronic pain patients, while improving the symptoms of OIBD, as the naloxone component blocks the effects of oxycodone at opioid receptors in the gut.
机译:慢性疼痛影响着世界各地的许多患者,并极大地影响了他们的生活质量,包括患者的睡眠,上班和社交的能力。英国疼痛协会提供了关于在慢性疼痛患者中使用阿片类药物的指南;然而,因疼痛而接受阿片类药物治疗的患者通常会出现与阿片类药物引起的肠功能障碍(OIBD)相关的症状,包括便秘。这些患者的便秘通常是泻药。但是,一项研究表明,有54%的患者无法通过这种方法获得理想的结果。羟考酮/纳洛酮片已被证明可为慢性疼痛患者提供镇痛作用,同时改善OIBD症状,因为纳洛酮成分可阻断羟考酮对肠道阿片受体的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号